Your trusted source for investing success

Tag: healthcare companies

Tech Forecast and Promising Tech Stocks To Buy in 2017

Learn about breakthrough technology about to impact lives around the globe. We cover the entire industry in our FREE investor’s report.   Gain Access

DIRTT Announces Changes to its Board of Directors

DIRTT Environmental Solutions (TSX:DRT) has announced that Todd W. Lillibridge has joined its board of directors and also announces the resignation of Diana Propper de Callejon, both effective August 2, 2017.

As quoted in the press release:
Lillibridge is Executive Vice President, Medical Property Operations at Ventas Inc. (NYSE:VTR) and brings more

3D Signatures’ TeloView Can Identify Alzheimer’s Patients

3D Signatures’ TeloView Can Identify Alzheimer’s Patients

3D Signatures Inc. (TSXV:DXD) has provided clinical study results which confirm that based on a swab from the inside of a patient’s cheek, its proprietary TeloView software platform has the ability to identify patients with Alzheimer’s disease (AD) and, furthermore, distinguish between mild, moderate and severe forms of the disease.

T2 Biosystems, Inc. Announces $50M Credit Facility

T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products that improve patient health and deliver a strong economic return to healthcare institutions, today announced that it has entered into a $50 million debt facility agreement with CRG LP. The new facility consists of an initial draw of $40 million

InteloMed, Inc. Announces Engagement of Investment Banking Firm Healthios Capital Markets, LLC as Exclusive Financial Advisor for Regulation D Private Placement

PITTSBURGH, PA–(Marketwired – Sep 6, 2016) –  InteloMed, Inc. (“InteloMed”), an emerging leader and developer of advanced non-invasive systems for patient monitoring and informatics, announced today that it has retained Healthios Capital Markets, LLC (“Healthios”), a premier investment bank focused on the global healthcare industry, as its exclusive financial advisor

Alpine Immune Sciences Announces $48 Million Series A Financing to Support Discovery and Development of the Next Generation of Immunotherapies

SEATTLE–(BUSINESS WIRE)–Alpine Immune Sciences, Inc., (AIS), a privately held biotechnology
company developing a next-generation immune system modulation platform,
today announced the closing of its $48 million Series A financing round.

The financing was led by OrbiMed Advisors, a leading investment firm
focused on the healthcare sector, alongside additional investors
including Frazier Healthcare Partners and Alpine

OPKO Health Announces Move to NASDAQ Stock Market

MIAMI–(BUSINESS WIRE)–OPKO Health, Inc. (NYSE:OPK) (“OPKO” or the “Company”) announces
that it will move its stock exchange listing to The NASDAQ Stock Market
from The New York Stock Exchange (the “NYSE”). The Company expects its
common stock will begin trading on the NASDAQ Global Select Market
(“NASDAQ”) on June 24, 2016, and its shares

Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
5 Top Weekly NASDAQ Tech Stock: Reports on Bitcoin Ban from China